Nawaloka Hospitals PLC (COSE:NHL.N0000)
Sri Lanka
· Delayed Price · Currency is LKR 5.50
+0.10 (1.85%)
At close: May 9, 2025
Nawaloka Hospitals Income Statement
Financials in millions LKR. Fiscal year is April - March.
Millions LKR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2015 - 2019 |
| Revenue | 10,757 | 10,379 | 9,305 | 15,302 | 11,828 | 9,036 | Upgrade
|
| Revenue Growth (YoY) | 4.70% | 11.54% | -39.19% | 29.38% | 30.90% | 5.88% | Upgrade
|
| Cost of Revenue | 4,959 | 4,763 | 4,670 | 7,461 | 6,285 | 4,248 | Upgrade
|
| Gross Profit | 5,798 | 5,617 | 4,635 | 7,841 | 5,542 | 4,788 | Upgrade
|
| Selling, General & Admin | 5,209 | 4,618 | 3,860 | 4,856 | 3,753 | 3,635 | Upgrade
|
| Other Operating Expenses | -70.58 | -37.47 | 258.91 | 232.59 | -37.37 | -61.96 | Upgrade
|
| Operating Expenses | 5,150 | 4,592 | 4,709 | 5,927 | 4,042 | 3,625 | Upgrade
|
| Operating Income | 648.14 | 1,025 | -73.46 | 1,914 | 1,501 | 1,163 | Upgrade
|
| Interest Expense | -944.49 | -1,491 | -1,951 | -1,035 | -1,162 | -1,335 | Upgrade
|
| Interest & Investment Income | 37.82 | 37.56 | 58.58 | 53.46 | 48.27 | 44.17 | Upgrade
|
| Earnings From Equity Investments | 148.53 | 148.53 | 159.89 | - | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | 33.73 | 33.73 | -102.56 | -215 | -24.4 | -25.72 | Upgrade
|
| Other Non Operating Income (Expenses) | 0 | - | -2.08 | -7.64 | -18.03 | -29.41 | Upgrade
|
| EBT Excluding Unusual Items | -76.27 | -247.01 | -1,911 | 709.67 | 344.61 | -182.87 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | -253.66 | 2.57 | 16.61 | Upgrade
|
| Pretax Income | -76.27 | -247.01 | -1,911 | 456.02 | 347.17 | -166.26 | Upgrade
|
| Income Tax Expense | 142.9 | 57.74 | 527.67 | 552.61 | -154.09 | -182.24 | Upgrade
|
| Net Income | -219.17 | -304.75 | -2,438 | -96.59 | 501.26 | 15.98 | Upgrade
|
| Net Income to Common | -219.17 | -304.75 | -2,438 | -96.59 | 501.26 | 15.98 | Upgrade
|
| Net Income Growth | - | - | - | - | 3036.68% | - | Upgrade
|
| Shares Outstanding (Basic) | 1,436 | 1,410 | 1,410 | 1,410 | 1,410 | 1,410 | Upgrade
|
| Shares Outstanding (Diluted) | 1,436 | 1,410 | 1,410 | 1,410 | 1,410 | 1,410 | Upgrade
|
| EPS (Basic) | -0.15 | -0.22 | -1.73 | -0.07 | 0.36 | 0.01 | Upgrade
|
| EPS (Diluted) | -0.16 | -0.22 | -1.73 | -0.07 | 0.36 | 0.01 | Upgrade
|
| EPS Growth | - | - | - | - | 3456.31% | - | Upgrade
|
| Free Cash Flow | 731.79 | 2,047 | 2,752 | 1,259 | -65.36 | -310.77 | Upgrade
|
| Free Cash Flow Per Share | 0.51 | 1.45 | 1.95 | 0.89 | -0.05 | -0.22 | Upgrade
|
| Gross Margin | 53.90% | 54.12% | 49.81% | 51.24% | 46.86% | 52.99% | Upgrade
|
| Operating Margin | 6.02% | 9.87% | -0.79% | 12.51% | 12.69% | 12.87% | Upgrade
|
| Profit Margin | -2.04% | -2.94% | -26.21% | -0.63% | 4.24% | 0.18% | Upgrade
|
| Free Cash Flow Margin | 6.80% | 19.73% | 29.58% | 8.23% | -0.55% | -3.44% | Upgrade
|
| EBITDA | 1,519 | 1,851 | 754.97 | 2,744 | 2,329 | 1,996 | Upgrade
|
| EBITDA Margin | 14.12% | 17.83% | 8.11% | 17.93% | 19.69% | 22.09% | Upgrade
|
| D&A For EBITDA | 870.89 | 825.97 | 828.43 | 830.28 | 828.33 | 832.56 | Upgrade
|
| EBIT | 648.14 | 1,025 | -73.46 | 1,914 | 1,501 | 1,163 | Upgrade
|
| EBIT Margin | 6.02% | 9.87% | -0.79% | 12.51% | 12.69% | 12.87% | Upgrade
|
| Effective Tax Rate | - | - | - | 121.18% | - | - | Upgrade
|
Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.